The Liver Care Trial

Launched by ZEALAND UNIVERSITY HOSPITAL · May 2, 2023

Keywords

ClinConnect Summary

The Liver Care Trial is a study aimed at understanding how measuring liver stiffness can help people with alcohol use disorders reduce their drinking or remain abstinent. The trial involves two groups: one group will receive an invitation for a liver stiffness test, blood sampling, and information on alcohol-related diseases, while the other group will only be invited for blood sampling. The main goal is to see if the first group is more likely to either stop drinking or limit their intake to 10 units of alcohol or less each week after six months.

To participate in this trial, individuals must be receiving outpatient treatment for alcohol use disorder and provide written consent. Unfortunately, those who do not speak Danish or English or have severe liver disease are not eligible to join. If you qualify, you can expect to be part of a supportive effort to improve liver health and reduce alcohol consumption, contributing to important research in this area.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Attending outpatient treatment for alcohol use disorder (international classification of disease version 10: F102: alcohol dependence or F101: harmful alcohol use) at Novavi Køge or Novavi Roskilde
• • Informed written consent
• Exclusion Criteria:
• • Not speaking Danish or English
• • Severe liver disease (known by the participant)